Drug General Information
| Drug Name |
Oxazepam
|
||
| Synonyms |
Abboxampam; Abboxapam; Adumbran; Alepam; Ansioxacepam; Anxiolit; Aplakil; Astress; Azutranguil; Azutranquil; Bonare; Drimuel; Droxacepam; Durazepam; Hilong; Isodin; Lederpam; Limbial; Murelax; Nesontil; Noctazepam; Nortemazepam; Nozepam; Ossazepam; Oxanid; Oxazepamum; Oxazipam; Oxozepam; Pacienx; Praxiten; Propax; Psicopax; Psiquiwas; QUEN; Quilibrex; Rondar; Sedigoa; Serax; Serenal; Serenid; Serepax; Seresta; Serpax; Sigacalm; Sobril; Tacepam; Tarchomin; Tazepam; Uskan; Vaben; Zaxopam; Anxiolit retard; Ossazepam [DCIT]; P acienx; CB 8092; DF2371850; O5254_SIGMA; Wy 3498; Z 10 tr; Alepam (TN); Apo-astress; Hi-Long; Medopam (TN); Murelax (TN); N-Desmethyltemazepam; Noripam (TN); Oxa-puren; Oxazepamum [INN-Latin]; Purata (TN); Ro 5-6789; Serax (TN); Serenid-D; Serepax (TN); WY-3498; Wy-3498 stic; Z10-Tr; Ox-Pam (TN); Tranquo-buscopan-wirkstoff; Oxazepam (JAN/USP/INN); Oxazepam [USAN:INN:BAN:JAN]; (+-)-7-Chloro-1,3-dihydro-3-hydroxy-5-phenyl-2H-1,4-benzodiazepin-2-one; (+-)-Oxazepam; (RS)-Oxazepam; 1,3-Dihydro-7-chloro-3-hydroxy-5-phenyl-2H-1,4-benzodiazepin-2-one; 1,3-Dihydro-7-chloro-3-hydroxy-5-phenyl-3H-1,4-benzodiazepin-2-one; 7-Chloro-1,3-dihydro-3-hydroxy-5-phenyl-1,4(2H)-benzodiazepin-2-one; 7-Chloro-1,3-dihydro-3-hydroxy-5-phenyl-2H-1,4-benzodiazepin-2-one; 7-Chloro-1,3-dihydro-3-hydroxy-5-phenyl-2H-1,4-benzodiazepine-2-one; 7-Chloro-3-hydroxy-5-phenyl-1,3-dihydro-2H-1,4-benzodiazepin-2-one; 7-chloro-3-hydroxy-5-phenyl-1,3-dihydro-1,4-benzodiazepin-2-one
|
||
| Drug Type |
Small molecular drug
|
||
| Indications |
Anxiety disorder [ICD-11: 6B00-6B0Z]
|
Approved
|
|
| Company |
Genus Pharms
|
||
| Summary |
Oxazepam is an intermediate-acting benzodiazepine with slow onset commonly used to treat panic disorders, severe anxiety, alcohol withdrawals, and insomnia.
|
||
| Target |
Translocator protein (TSPO)
Mechanism of Action: Agonist
|
T75440 | |
Drug Chemical Infomation and External Links
|
Formula |
C15H11ClN2O2
|
| Canonical SMILES |
C1=CC=C(C=C1)C2=NC(C(=O)NC3=C2C=C(C=C3)Cl)O
|
|
| InChI |
1S/C15H11ClN2O2/c16-10-6-7-12-11(8-10)13(9-4-2-1-3-5-9)18-15(20)14(19)17-12/h1-8,15,20H,(H,17,19)
|
|
| InChIKey |
ADIMAYPTOBDMTL-UHFFFAOYSA-N
|
|
| CAS Number | CAS 604-75-1 | |
| TTD ID | D09LDR | |
| DrugBank ID | DB00842 | |
| PubChem Compound ID | 4616 | |
| PubChem Substance ID |
9563
,
442236
,
3249122
,
5195891
,
7847530
,
7849644
,
7980215
,
8145938
,
8150141
,
8152833
,
10529275
,
11336161
,
11361400
,
11462372
,
14848993
,
24898014
,
29215230
,
29223705
,
46506031
,
47515395
,
47959852
,
48414263
,
48416359
,
48423875
,
49854270
,
49884181
,
50775696
,
53787011
,
56311180
,
57322352
,
87689980
,
99233239
,
99302074
,
103179009
,
104306922
,
124892098
,
124892099
,
125824328
,
126671574
,
127390117
,
134337557
,
134977280
,
135343430
,
136351131
,
137089237
,
137203466
,
137261518
,
140053015
,
144205125
,
144206372
|
|
| ChEBI ID | CHEBI:7823 | |
| ADReCS Drug ID | BADD_D01636 |
Drug-Food (Herb) Interactions
- Drug
- Foods
- Herbs
- Positive
- Negative
- Possible
- Harmful
- No Effect
| ID | Name | Dose | Type | Drug Brand Name | Drug Dose | Drug Dosage Form | Experimental Species | Individuals Number | Test Sample | Ingredient | Effect | Relationship Classification | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ID | Name | Dose | Type | Drug Brand Name | Drug Dose | Drug Dosage Form | Experimental Species | Individuals Number | Test Sample | Ingredient | Effect | Relationship classification |